Skip to main content

Site notifications

CABENUVA cabotegravir 400 mg/2 mL plus rilpivirine 600 mg/2 mL prolonged-release suspensions for injection vials (2023-24)

Product name
CABENUVA cabotegravir 400 mg/2 mL plus rilpivirine 600 mg/2 mL prolonged-release suspensions for injection vials
Sponsor name
ViiV Healthcare Pty Ltd
Year Range
2023-24

Help us improve the Therapeutic Goods Administration site